Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C.
about
Mechanisms of Hepatitis C Viral Resistance to Direct Acting AntiviralsMapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development.Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals.Sofosbuvir plus simeprevir for the treatment of genotype 1 chronic hepatitis C: a review of evidence.A Simple but Accurate Method for Evaluating Drug-Resistance in Infectious HCVcc System.Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment.Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis.Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy.Epidemic history of hepatitis C virus genotypes and subtypes in PortugalPipeline for specific subtype amplification and drug resistance detection in hepatitis C virus
P2860
Q26773321-D53475EE-CBF0-4456-9E7E-1D389CC2C626Q37354049-65E276ED-2DA3-43AD-88FC-AB0513972E21Q38779980-27F73319-871E-4224-AEF1-CC6A6B00F6E3Q38954096-590415FF-6DEF-4EA9-A2FF-34DB81958A75Q40042032-28B27E1D-0104-4E68-AB56-E2DC9BE9B349Q40301168-15006CCB-5250-4EA3-8A8A-5189C6AE19DAQ49911983-6681C75E-1524-462D-A420-18D255E6588FQ55303958-53AFB90E-5723-420C-9C47-7EC9400AC998Q55379857-474C827C-4968-4510-97AF-842084162457Q56395674-6DA5BDD6-AC5F-4B4F-A9AB-727B17D5C93FQ58768677-95DC2E4F-ACDE-482A-A51F-78485919BC40
P2860
Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Naturally occurring mutations ...... ents with chronic hepatitis C.
@ast
Naturally occurring mutations ...... ents with chronic hepatitis C.
@en
type
label
Naturally occurring mutations ...... ents with chronic hepatitis C.
@ast
Naturally occurring mutations ...... ents with chronic hepatitis C.
@en
prefLabel
Naturally occurring mutations ...... ents with chronic hepatitis C.
@ast
Naturally occurring mutations ...... ents with chronic hepatitis C.
@en
P2093
P2860
P50
P1433
P1476
Naturally occurring mutations ...... ents with chronic hepatitis C.
@en
P2093
Anna Rita Ciccaglione
Enea Spada
Nicola Coppola
P2860
P356
10.1186/S12985-015-0414-1
P50
P577
2015-11-14T00:00:00Z